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Abstract
Background: Obstetric fistula is a serious medical condition which affects women in low income countries. Despite the
progress of research on fistula, there is little data on long term follow-up after surgical repair. The objective of this study
is to analyse the factors associated with the recurrence of fistula and the outcomes of pregnancy following fistula repair
in Guinea.
Methods: A descriptive longitudinal study design will be used. The study will include women who underwent fistula
repair between 2012 and 2015 at 3 fistula repair sites supported by the Fistula Care Project in Guinea (Kissidougou
Prefectoral Hospital, Labé Regional Hospital and Jean Paul II Hospital of Conakry).
Participants giving an informed consent after a home visit by the Fistula Counsellors will be interviewed for enrolment at
least 3 months after hospital discharge The study enrolment period is January 1, 2012 − June 30, 2015. Participants will
be followed-up until June 30, 2016 for a maximum follow up period of 48 months. The sample size is estimated at 364
women.
The cumulative incidence rates of fistula recurrence and pregnancy post-repair will be calculated using Kaplan-Meier
methods and the risk factor analyses will be performed using adjusted Cox regression. The outcomes of pregnancy will
be analysed using proportions, the Pearson’s Chi Square (χ2) and a logistic regression with associations reported as risk
ratios with 95 % confidence intervals. All analyses will be done using STATA version 13 (STATA Corporation, College
Station, TX, USA) with a level of significance set at P < 0.05.
Discussion: This study will contribute to improving the prevention and management of obstetric fistula within the
community and support advocacy efforts for the social reintegration of fistula patients into their communities. It will also
guide policy makers and strategic planning for fistula programs.
Trial registration: ClinicalTrials.gov Identifier: NCT02686957. Registered 12 February 2016 (Retrospectively registered).
Keywords: Recurrence, Pregnancy, Risk factors, Obstetric fistula, Post-repair, Guinea
Background
Obstetric fistula (OF) is a serious medical condition in
which a perforation develops between vagina, bladder
and/or rectum, most commonly after prolonged labour
when the head of the unborn child compresses the birth
canal and leads to tissue necrosis [1, 2]. A recent study
in 5 countries showed that women suffering from OF
are generally married young, have little formal education
and for most of them the fistula occurred after the first
pregnancy, at a median age of 20 years [3]. The condi-
tion hardly exists in the developed world, but remains
prevalent in sub-Saharan Africa, especially in countries
where access to quality emergency obstetric care is low
[4, 5]. Guinea for instance has a high maternal mortality
ratio (724 per 100 000 live births) and a prevalence of
OF among women of reproductive age estimated to be
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0.6 %, which represents a total number of 15 − 18 thou-
sands women living with an OF [6].
Thanks to the international mobilization against fistula
in recent years, the holistic care of OF (prevention, treat-
ment and reintegration) in many sub-Saharan African
countries has improved [7, 8]. As a result, immediate
post-operative closure rates of OF have increased [9–12].
In addition, the number of repaired women has increased
worldwide with more than 30,000 fistula repairs supported
by the Fistula Care Project in 15 countries since 2005
[13] and more than 57,000 repairs funded by the
UNFPA over the past decade [14]. Furthermore, new
evidence has shown that women’s hospital stay can be
shorten and costs lowered, allowing more women to
be treated [15]. In Guinea, about 3,000 fistulas were
repaired between 2007 and 2013 by the Fistula Care
Project (a USAID-funded project managed by Engen-
derHealth) [13, 16].
Despite these improvements, gaps still exist, especially
in the long term follow-up of women after successful
fistula repair [17]. In fact, data currently available show
that delivery leading to fistula usually ends up with a
stillbirth [10–12] and that women are relatively young at
the time their fistula is repaired [3]. Therefore, when
successfully repaired, women return to their community
with the desire to resume social and sexual life, and have
children [18–20]. However, this return to sexuality
exposes repaired woman to pregnancy and childbirth,
which increases the risk of recurrence of a previously
repaired fistula or the formation of a second, new fistula
[18, 19]. Fear of recurrence of fistula is a constant worry
for women successfully repaired of OF [21–23] and,
given the cost of fistula care and the lower success of
repairing [24], these women might need more attention
to prevent recurrence of fistula and adverse pregnancy
outcomes.
There is no precise estimate of the recurrence of
fistula or pregnancy after OF repair. In Ethiopia, Nielsen
et al [18] observed 2.63 % re-occurrence of fistula among
38 women in a 21 months’ post-repair median follow up
and Browning and Menber [19] recorded 4.26 % in 141
women successfully repaired after 6 months’ follow-up.
In Malawi, Wilson et al [20] reported 3.85 % of re-
occurrence in 26 women after 9 − 24 months’ follow-up
post-repair.
The same authors found a proportion of pregnan-
cies of respectively 13.16 % [18] and 4.26 % [19] in
Ethiopia and 23.10 % in Malawi [20]. Delivery out-
comes were poor with only 1 live birth reported in
both Ethiopia and Malawi [18, 20]. Heavy work, sex-
ual intercourse, and delivery have been reported to be
associated with the recurrence of fistula [25–28].
Because sexuality and desire of children are part of
women’s life after successful OF repair [18, 19, 21, 29]
and recurrence of fistula and stillbirth are very common
complications of delivery post OF repair [18, 20],
there is a need for more well powered long term
follow-up studies that could fill the existing gap of
knowledge. The need to collect long-term follow-up
data about fistula recurrence, subsequent pregnancies
and their outcomes has already been identified among
current research priorities on fistula [17]. Since, there
has been no major comprehensive and well powered
study initiated in a sub-Saharan African country in-
volving women after OF repair, and for the status of
the fistula at discharge is not always specified in
the existing studies, we initiated this study with the
following objectives:
 Analyse the incidence rate and risk factors of fistula
recurrence up to 48 months follow up.
 Analyse the incidence rate and factors associated
with pregnancy and pregnancy outcomes (maternal
and perinatal) up to 48 months’ follow-up;
The endpoints will be recurrence of fistula, pregnancy,
abortion or miscarriage, maternal, perinatal and child
death at any time from hospital discharge.
Methods
Study design
This is a longitudinal follow-up study over a period of 4
years conducted among women underwent fistula repair
at 3 sites supported by Engenderhealth in Guinea. A
cohort will be constituted. Participants who have been
repaired at OF treatment sites before the study has
started will be included retrospectively and then
followed up prospectively (Fig. 1).
The primary outcome is the incidence rate of the
recurrence of fistula. For the purpose of this study,
recurrence of fistula includes the breakdown of a
repaired fistula or the occurrence of a new fistula in
study participants. At the study sites, the closure of
fistula was determined at hospital discharge by a pelvic
exam using a dye test. During follow-up visits, women
will first be asked about current medical status using the
question “does the woman have continuous and uncon-
trolled leakage of urine?”. If the answer is “YES” then
women will be scheduled for a pelvic exam with a dye
test for confirmation, at the nearest health facility
(health centre or health post). This question is always
used at EngenderHealth supported sites to assess women
at reception, before further pelvic exam. In addition, the
presence of “continuous and uncontrolled leakage of
urine” is commonly used as a screening question for
fistula in circumstances in which a pelvic exam is not
possible (e.g. Demographic and Helath Surveys, DHS); it
differentiates between fistula and other forms of
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incontinence, which are unlikely to be continuous and
uncontrolled. In some cases, it might not be feasible to
perform the dye test if for instance the woman refuses
to go to a health facility. This might lead to a misclassifi-
cation which can bias the estimate towards a null. How-
ever, misclassification is unlikely, since women with
continued urinary leakage are eager to report their expe-
riences in order for the condition to be rectified.
The secondary outcomes include pregnancy and preg-
nancy and outcomes (miscarriage or abortion or term
pregnancy). Pregnancy and pregnancy outcomes will be
documented by a positive pregnancy test from discharge
(done at recruitment or during follow-up visit or given
at any time by a result from medical records such as
antenatal (ANC) card) or by a self-reporting corrobo-
rated by 2 witnesses. Maternal status at delivery and
mode of delivery (dead or alive; caesarean section or
normal delivery; no complication or any complication)
will be assessed by looking at the ANC & Delivery card
or hospital records or self-reporting. Child outcome at
delivery (stillbirth, neonatal death or alive) will be
assessed by looking at the ANC & Delivery card or
hospital records or self-reporting corroborated by 2
witnesses.
Our predictors of interest will include patient charac-
teristics, fistula characteristics, context of repair and
context of reintegration. Because women will be
recruited and followed-up to record the occurrence of
the study outcomes over a period of time, the longitu-
dinal follow-up study design is the most suitable design.
Study setting
General setting
Guinea is a coastal West African country with an esti-
mated population of 12 million people [6]. The popu-
lation is largely rural (65 %) and poor [30]. The
Guinean health care system faces many challenges,
including chronic shortage of qualified physicians and
nurses, and poor clinical infrastructure, particularly in
rural and mountainous areas. According to the
national action plan for repositioning family planning
in Guinea 2014–2018 [20], only 16 % of health profes-
sionals (doctors, state midwives and state nurses) work
in rural areas where they serve 65 % of the population.
Guinea has an estimated lifetime prevalence of obstet-
ric fistula of 0.6 % among women aged 15–49 which
ranges regionally from 0.2 to 1.2 % [6], although this
figure is likely underestimated. Challenging contextual
factors in maternal health include low modern contra-
ceptive prevalence (6 %), concurrent high fertility rate
of 5.1, and high maternal mortality (724 deaths per
100,000 live births) [6]. Over the period 2007–2012,
the majority of births (54.7 %) were assisted by
untrained individuals, and occurred at home (58.8 %)
[6]. Since 2012, the Ministry of Health has elaborated
a national strategic plan (2012–2016) for the preven-
tion and treatment of fistula [16]. This strategic plan
emphasizes the importance of reintegration and
support to victims of OF and advocates for more oper-
ational and action research that can inform policy.
Specific setting
Fistula repair services are available in 4 sites across
the country but the study will be conducted with
women successfully repaired at the 3 Engenderhealth
supported hospitals. From 2007 to 2013, about 3000
OF repairs have been conducted at the 3 Engender-
health supported sites (Jean Paul II Hospital in
Conakry, the Regional Hospital of Labé and the Pre-
fectural Hospital of Kissidougou), where 16 physicians
have been trained in obstetric fistula repair, 55 nurses/
midwives have been trained in fistula management
and 400 − 450 fistula repairs per year have been
performed [13].
Study population
The study population includes all women who under-
went successful repair of OF from January 1, 2012 −
June 30, 2015 at the 3 above described fistula repair
sites.
Fig. 1 Study flow chart
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Sample size calculation
For the estimation of the incidence rate of the recurrence
of fistula, we used the 2-Sided Confidence Intervals for 1
Proportion Confidence Interval Formula [31]. Using the
existing data [19] and considering a +/- 2 % margin of
error and 95 % confidence interval, we estimate the sam-
ple size of the cohort to be 280. We anticipate 20 % loss
to follow-up and 10 % refusal rate and accordingly
increase the sample size to 364. The same formula pro-
vides an estimation of the sample size for the incidence
rate of pregnancy [31]. If we estimate the rate of preg-
nancy to be around 20 % at 24 months’ follow-up among
successfully repaired women [20], a sample size of 264
women produces a 2-sided 95 % confidence interval with
10 % precision. Therefore, the sample size of 364 women
will be sufficient to describe the objective on pregnancy
and its outcomes.
Participants’ recruitment and follow-up
All women who underwent successful repair of OF from
January 1, 2012 to June 30, 2015 at the 3 study sites are
eligible for inclusion in study. However, only women with
a unique obstetric fistula that was closed at discharge, as
measured by a dye test, who provide written informed
consent, reside in Guinea and agree with follow-up visits
will be included in the study (Fig. 1). Eligible participants
who refuse informed consent, who got repair outside the
study sites or whose medical records are incomplete will
be excluded.
Individual medical records of all women who benefited
fistula repair at the 3 sites in 2012–2015 will be screened
by the study team to identify those who were discharged
with a close fistula (Fig. 1). After locating them through
their medical records, the study team (that includes
nurses called “Fistula Counsellors” who are involved in
the management of women at the fistula repair sites) will
contact women by home visit in their community to
obtain informed consent.
Once the informed consent is obtained, the woman
will be interviewed for 30 − 60 min by the study team
and examined in an isolated place for inclusion in the
study. Later, her medical records will be used at the
fistula repair site where she got the surgery to collect
her sociodemographic and clinical characteristics at the
time of surgery. For all women recruited in the study,
most retrospectively, new fistula or recurrence of the
repaired fistula, pregnancies and their outcomes (miscar-
riage, stillbirth, live birth, early new-born death, mater-
nal death, and type of maternal complication) will be
documented. Health Centres and Health posts around
which the study participants live will be used by the
study team to perform the dye test in women who report
“Continuous and uncontrolled leaking” since discharge
or at the follow up visit.
Study procedures
The study team will retrospectively screen individual
medical records of all women who benefited fistula
repair at the 3 sites from January 1, 2012 to June 30,
2015 to identify those who were discharged with a close
fistula (Table 1 and Fig. 2).
A home visit will then be conducted within the com-
munity to seek informed consent with the repaired
women. After obtaining the consent, women will be
interviewed. Women who report “Continuous and
uncontrolled leaking” since the last follow-up visit will
be scheduled for a pelvic exam and a dye test at the
nearest health centre or health post. If the case is con-
firmed as fistula (by a dye test of clinical exam), the
woman will be counselled and referred to the nearest fis-
tula repair centre. By this approach, we think that any
misclassification of outcome (recurrence of fistula) will
be minimal, since women with any continuous and un-
controlled leakage of urine following repair are likely to
report it, and any reported incontinence will be evalu-
ated by a dye test.
If a woman reports pregnancy, she will be asked to
show her antenatal care (ANC) & delivery card on which
pregnancy test result is routinely reported. If possible, a
pregnancy test will be performed. Otherwise, investiga-
tors will rely on woman self-reporting.
Sociodemographic and clinical characteristics of women
will be collected from individual medical records at each
participating fistula repair site.
All investigators will receive appropriate training at
the Maferinyah National Research and Training Centre
before they go in the field.
Data collection
Recruitment and follow-up visit
The enrolment and follow up data are collected using
structured and pre tested standardised questionnaires.
Both questionnaires will include participants’ current
fistula status (fistula close and continent/closed but not




Screening • Retrieving of medical records
• Identification of women closed at discharge
Enrolment • Home visit to seek informed consent
• Administering of inclusion questionnaire
• Dye test at nearest health post/centre
• Appropriate referral when needed




• Home visit to administer follow up questionnaire
• Dye test at nearest health post/centre
• Appropriate referral when needed
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continent), post-operative social and reproductive life
(marital status, occupation, sexuality, use of modern
contraceptive methods, pregnancy, childbirth), and any
fistula related complication. Participants’ current full
address is also collected to facilitate communication,
referral and follow-up visits.
Sociodemographic and clinical characteristics
After obtaining the informed consent during the recruit-
ment visit, a standardised questionnaire called Baseline
form is used to collect the demographic and clinical
characteristics of women from hospital records in the
hospitals where they were discharged from. This ques-
tionnaire includes age at presentation at hospital, marital
status, age at marriage, occupation, level of education,
residence (rural/urban), number of pregnancies, parity,
number of previous repairs, and duration of fistula.
Clinical characteristics include mode of delivery related
to development of the fistula, neonatal outcome at
causal delivery, type of fistula (VVF, RVF or both), status
of the bladder neck, nature of the fistula according to
the surgeon (simple versus complex), duration of
catheterization after repair, status of the operating
surgeon (expatriate, local trainer, local trainee), postop-
erative complications, context of repair (routine repair
or pooled repair) and the status of the fistula at dis-
charge (close and continent/Close but not continent).
Data management
Study forms will be checked after data collection before
sending to the Maferinyah Training and Research Centre
in a sealed envelope where they will be stored in a
locked cabinet. Data will be double entered by 2 inde-
pendent encoders into a data entry file created using
EpiData Entry software (EpiData Association, Odense,
Denmark). Reliability will be checked and any inconsist-
encies in data entry will be resolved. It is planned to per-
form data entry on a continuous basis from the start of
enrolment so that discrepancies are addressed while data
collection is ongoing. Data entry screens will be created
for each form used in the study. The database will be
password protected and only authorized users will be
given access. All data will be stored in a GCP compliant
server, and data management will respect patient
confidentiality.
All study documents with the participant’s name (i.e.
participants’ contact form) will be kept in a strict
confidentiality.
Data analysis
Categorical data and treatment outcomes will be sum-
marized as frequencies (%) and compared using χ2 or
Fisher’s exact tests as appropriate. Continuous data will
be presented using median (interquartile range) and
compared using the Wilcoxon rank-sum test. Follow-up
will be calculated from the date of hospital discharge.
The date of fistula recurrence or the estimated date of
pregnancy will be selected as the date of events. Patients
who do not experience recurrence of fistula or preg-
nancy will be censored at the last follow up visit. For
patients who are reported dead (by the relatives), the
date of death will be used to determine their follow-up
time in the study. For patients who are lost to follow up
(i.e. who move from their village without any address to
joint them after inclusion) the date of the last visit will
be used.
Socio-demographic and clinical differences between
those women who remain in the study and those who
are lost-to-follow-up will be estimated to check for any
imbalances at inclusion.
The incidence of fistula recurrence and that of
pregnancy will be estimated using the method of
cumulative incidence. The cumulative incidence rate
will be compared across risk factors using Kaplan-
Meier methods. Exposure variables with a P-value
<0.2 in the univariate analysis will be included in
multivariate models. Exposure variables with a P-value
<0.2 in the univariate analysis will be included in
multivariate models. A risk factor analysis will be per-
formed using adjusted Cox regression. Associations
will be reported as adjusted hazard ratios with 95 %
CIs. Analysis will be done using STATA version 12
(STATA Corporation, College Station, TX, USA) with
a level of significance will be set at P < 0.05.
Fig. 2 Study timeline
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For the outcomes of pregnancy (miscarriage or abortion,
mother and child status at delivery), Pearson’s Chi square
(χ2) will be used to compare proportions of these outcomes
between potential exposure variables (age group, previous
repair (Yes/No), fistula status at hospital discharge, use of
antenatal care, delivery by caesarean section, etc.). Logistic
regression analysis and models will be used and associa-
tions will be reported as risk ratios with a level of signifi-
cance set at P = 0.05 and a 95 % confidence intervals.
Discussion
This longitudinal study will generate long-term follow-up
data on fistula recurrence, subsequent pregnancies and
their outcomes among women who underwent successful
fistula repair in order to guide policy making and strategic
planning in Guinea. This will improve current and future
programmes for fistula management and care. The findings
will also contribute towards improving programme per-
formance and support advocacy efforts for better reintegra-
tion of fistula patients in Guinea and beyond.
This study has a number of strengths. First the
protocol employs appropriate design and analytical
methods, and a well powered sample size. Second, it
will take advantage of the large collection of long
term data assessing the recurrence of fistula and the
outcomes of pregnancy. Third, it will add to previous
studies examining fistula recurrence and reproductive
outcomes after obstetric fistula repair by assessing a
wide variety of variables, and by adjusting for poten-
tial confounding factors.
The results of this study and its potential implications
will be made known to health care staff in the study
sites, as well as the national level. National and inter-
national platforms will be used to disseminate study
findings and the results will be presented at international
conferences and published in peer reviewed journals.
Since the findings might be applicable to other fistula
care and management programmes in neighbouring
countries, the lessons learnt might have wider benefit.
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